Whelan, K A
Chandramouleeswaran, P M
Tanaka, K
Natsuizaka, M
Guha, M
Srinivasan, S
Darling, D S
Kita, Y
Natsugoe, S
Winkler, J D
Klein-Szanto, A J
Amaravadi, R K
Avadhani, N G
Rustgi, A K
Nakagawa, H
Article History
Received: 4 May 2016
Revised: 16 February 2017
Accepted: 8 March 2017
First Online: 17 April 2017
Competing interests
: The authors declare no conflict of interest. Drs Ravi K Amaravadi and Jeffrey D Winkler have licensed Lys05 to Presage biosciences for development. The other authors declare no conflict of interest.